FDA reverses decision to pull Shire drug; India eyes task force on pharma competition;

@FiercePharma: Docs more receptive to reps at industry confabs. Article | Follow @FiercePharma

> After a flood of consumer complaints, the FDA backtracked on its decision to pull Shire's midodrine off the market because of a lack of follow-up trial data. Report

> The Indian government has decided to charge a task force with considering its pharmaceutical industry's future, in light of recent foreign buyouts and other incursions into the domestic market. Report

> A version of Bayer's erectile dysfunction drug Levitra that dissolves on the tongue has been given the green light by regulators in Europe. Report

> A federal jury returns to deliberate the case of a New Hampshire woman seeking more than $24 million from the maker of a prescription drug she took to ease shoulder pain, but suffered a reaction so severe the is now blind and scarred by burns. Report

> ProStrakan's chief executive resigned after manufacturing problems and more delays to the approval of its cancer-pain drug in the U.S. heaped pressure on the drug company. Report

> Icelandic drugmaker Actavis said on Tuesday it aimed to join the race to develop generic copies of pricey biotech medicines by buying a majority stake in Polish group Bioton's BioPartners unit. Report

Biotech News

 @FierceBiotech: Roche plots layoffs as it focuses on R&D. Story | Follow @FierceBiotech

 @JohnCFierce: Ooh. Celldex shares (a) plunge (b) swoon (c) dive or (d) in a meltdown ? | Follow @JohnCFierce

> ReMYND scores $637 million CNS development deal with Roche. News

> Idenix shares crash after tox scare forces hold on hep C drugs. Report

> Sanofi hints at higher Genzyme bid as GSK remains on the sidelines. Article

> Biovail-Valeant combo will cost 25 percent of all jobs. Item

Biotech Research News

> New Novartis drug cures malaria in mice. Story

> Sending chimps back to the lab triggers controversy. Report

> Heart researchers hunt for drugs that rein in mystery protein. News

> Scientists enlist cockroaches in the war against superbugs. Report

> Gut microbes could offer new therapeutic platform. Article

Biotech IT News

> Study-data conflicts complicate Plavix research. News

> CRF Health gets certified for COPD tool. Report

> Pharma near top in litigation risk thanks to social media, Web 2.0. Report

Manufacturing News

> Big pharma pounces on South Africa. News

> Daiichi continues slow turn of Ranbaxy ship. Report

> Drug shortages fuel big pharma suspicions. Story

> Stolen epilepsy drug resurfaces two years later. News

> China's contractor shine losing luster. Article

And Finally ... Cockroach brains may be a source of new antibiotics capable of killing deadly drug-resistant bacteria. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.